Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoh Takekuma

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Scientific Reports|November 9, 2023
Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatmentYoshitaka Saito, Shinya Tamaki, Daisuke Hirate, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2022
Association between skin immune-related adverse events (irAEs) and multisystem irAEs during PD-1/PD-L1 inhibitor monotherapyAtsushi Yamaguchi, Yoshitaka Saito, Katsuya Narumi, et al.
European Journal of Clinical Pharmacology|September 21, 2002
Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese populationMasahiro Hiratsuka, Yoh Takekuma, Naomi Endo, et al.
Anticancer Research|May 31, 2022
Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration MethodYoshitaka Saito, Yoh Takekuma, Masaki Kobayashi, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 24, 2024
Validated UPLC-MS/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samplesHina Ishikawa, Ayako Furugen, Ayako Nishimura, et al.
Oral Diseases|September 28, 2023
Development of a risk prediction model for surgical site infection after lower third molar surgeryAkira Yamagami, Katsuya Narumi, Yoshitaka Saito, et al.
Journal of Clinical Pharmacy and Therapeutics|March 7, 2022
Evaluation of the strategies to reduce third-generation oral cephalosporins in dentistry at a Japanese academic hospital: An interrupted time series analysisAkira Yamagami, Katsuya Narumi, Yoshitaka Saito, et al.
In Vivo (Athens, Greece)|October 30, 2024
Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor MonotherapyAtsushi Yamaguchi, Yoshitaka Saito, Keisuke Okamoto, et al.
Biological & Pharmaceutical Bulletin|June 19, 2024
Evaluation of Efficacy of Adding Aprepitant to Palonosetron and Dexamethasone in Carboplatin and Etoposide TherapyTatsuhiko Sakamoto, Moeko Kado, Yoshitaka Saito, et al.
Scientific Reports|October 10, 2023
Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patientsYoshitaka Saito, Masaki Kobayashi, Shinya Tamaki, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Scientific Reports|November 9, 2023
Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatmentYoshitaka Saito, Shinya Tamaki, Daisuke Hirate, et al.
Journal of Cancer Research and Clinical Oncology|November 8, 2022
Association between skin immune-related adverse events (irAEs) and multisystem irAEs during PD-1/PD-L1 inhibitor monotherapyAtsushi Yamaguchi, Yoshitaka Saito, Katsuya Narumi, et al.
European Journal of Clinical Pharmacology|September 21, 2002
Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese populationMasahiro Hiratsuka, Yoh Takekuma, Naomi Endo, et al.
Anticancer Research|May 31, 2022
Suitability of Oral Rehydration Solution (ORS) for Use in the Cisplatin Short Hydration MethodYoshitaka Saito, Yoh Takekuma, Masaki Kobayashi, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 24, 2024
Validated UPLC-MS/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samplesHina Ishikawa, Ayako Furugen, Ayako Nishimura, et al.
Oral Diseases|September 28, 2023
Development of a risk prediction model for surgical site infection after lower third molar surgeryAkira Yamagami, Katsuya Narumi, Yoshitaka Saito, et al.
Journal of Clinical Pharmacy and Therapeutics|March 7, 2022
Evaluation of the strategies to reduce third-generation oral cephalosporins in dentistry at a Japanese academic hospital: An interrupted time series analysisAkira Yamagami, Katsuya Narumi, Yoshitaka Saito, et al.
In Vivo (Athens, Greece)|October 30, 2024
Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor MonotherapyAtsushi Yamaguchi, Yoshitaka Saito, Keisuke Okamoto, et al.
Biological & Pharmaceutical Bulletin|June 19, 2024
Evaluation of Efficacy of Adding Aprepitant to Palonosetron and Dexamethasone in Carboplatin and Etoposide TherapyTatsuhiko Sakamoto, Moeko Kado, Yoshitaka Saito, et al.
Scientific Reports|October 10, 2023
Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patientsYoshitaka Saito, Masaki Kobayashi, Shinya Tamaki, et al.
Pageof 18